Theravance Biopharma, Inc. (TBPH)
After hours:
| Previous Close | 9.47 |
| Open | 9.45 |
| Bid | 9.35 x 400 |
| Ask | 9.39 x 200 |
| Day's Range | 9.25 - 9.60 |
| 52 Week Range | 8.21 - 11.71 |
| Volume | |
| Avg. Volume | 400,832 |
| Market Cap | 459.863M |
| Beta (5Y Monthly) | 0.36 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.00 |
| Earnings Date | May 13, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 15.40 |
PR NewswireTheravance Biopharma to Participate in an Upcoming Investor Conference
Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a Fireside Chat at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ Monday, May 20 at 11:30 AM EDT (8:30 AM PDT / 4:30 PM IST) and will be hosting in-person meetings with the investment community at the conference.
- PR Newswire
Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024
Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its first quarter 2024 financial results and provide a business update after market close on Monday, May 13, 2024. An accompanying conference call and simultaneous webcast will be hosted at 5:00 pm ET (2:00 pm PT/10:00 pm IST) that day.
ZacksStrength Seen in Theravance Bio (TBPH): Can Its 7.6% Jump Turn into More Strength?
Theravance Bio (TBPH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
